Vascular endothelial growth factor in the ischemic retina and its regulation by somatostatin

Journal of Neurochemistry

Volumn 120, Issue 5, 2012, Pages 818-829

  Cervia, Davide ^a   Catalani, Elisabetta ^a   Dal Monte, Massimo ^b   Casini, Giovanni ^a  

^a UNIVERSITY OF TUSCIA   (Italy)

^b UNIVERSITY OF PISA   (Italy)

Author keywords

neuroprotection; quantitative image analysis; somatostatin receptor 2

Indexed keywords

MESSENGER RNA; SOMATOSTATIN RECEPTOR 2; VASCULOTROPIN;

ANIMAL TISSUE; ARTICLE; CELL PROTECTION; CONTROLLED STUDY; EX VIVO STUDY; FEMALE; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN SECRETION; RECEPTOR UPREGULATION; RETINA ISCHEMIA; RETINA NERVE CELL; WILD TYPE;

ANIMALS; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; EYE PROTEINS; FEMALE; GENE EXPRESSION REGULATION; ISCHEMIA; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NERVE TISSUE PROTEINS; NEURONS; OCTREOTIDE; RECEPTORS, SOMATOSTATIN; RETINA; RETINAL VESSELS; RNA, MESSENGER; SOMATOSTATIN; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

MUS;

EID: 84857191034     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2011.07622.x     Document Type: Article

References (60)

1. Abdallah W., and, Fawzi A. A., (2009) Anti-VEGF therapy in proliferative diabetic retinopathy. Int. Ophthalmol. Clin. 49, 95-107.
2. Arjamaa O., and, Nikinmaa M., (2006) Oxygen-dependent diseases in the retina: role of hypoxia-inducible factors. Exp. Eye Res. 83, 473-483.
3. Bigiani A., Petrucci C., Ghiaroni V., Dal Monte M., Cozzi A., Kreienkamp H. J., Richter D., and, Bagnoli P., (2004) Functional correlates of somatostatin receptor 2 overexpression in the retina of mice with genetic deletion of somatostatin receptor 1. Brain Res. 1025, 177-185.
4. Brandstatter J. H., Fletcher E. L., Garner C. C., Gundelfinger E. D., and, Wassle H., (1999) Differential expression of the presynaptic cytomatrix protein bassoon among ribbon synapses in the mammalian retina. Eur. J. Neurosci. 11, 3683-3693.
5. Campochiaro P. A., (2006) Ocular versus extraocular neovascularization: mirror images or vague resemblances. Invest. Ophthalmol. Vis. Sci. 47, 462-474.
6. Cao J., Mathews M. K., McLeod D. S., Merges C., Hjelmeland L. M., and, Lutty G. A., (1999) Angiogenic factors in human proliferative sickle cell retinopathy. Br. J. Ophthalmol. 83, 838-846.
7. Casini G., Dal Monte M., Petrucci C., Gambellini G., Grouselle D., Allen J. P., Kreienkamp H. J., Richter D., Epelbaum J., and, Bagnoli P., (2004) Altered morphology of rod bipolar cell axonal terminals in the retinas of mice carrying genetic deletion of somatostatin subtype receptor 1 or 2. Eur. J. Neurosci. 19, 43-54.
8. Casini G., Catalani E., Dal Monte M., and, Bagnoli P., (2005) Functional aspects of the somatostatinergic system in the retina and the potential therapeutic role of somatostatin in retinal disease. Histol. Histopathol. 20, 615-632.
9. Catalani E., Cervia D., Martini D., Bagnoli P., Simonetti E., Timperio A. M., and, Casini G., (2007) Changes in neuronal response to ischemia in retinas with genetic alterations of somatostatin receptor expression. Eur. J. Neurosci. 25, 1447-1459.
10. Catalani E., Tomassini S., Dal Monte M., Bosco L., and, Casini G., (2009) Localization patterns of fibroblast growth factor 1 and its receptors FGFR1 and FGFR2 in postnatal mouse retina. Cell Tissue Res. 336, 423-438.
11. Celiker U., and, Ilhan N., (2002) Nitric oxide and octreotide in retinal ischemia-reperfusion injury. Doc. Ophthalmol. 105, 327-338.
12. Cervia D., Martini D., Ristori C., Catalani E., Timperio A. M., Bagnoli P., and, Casini G., (2008) Modulation of the neuronal response to ischaemia by somatostatin analogues in wild-type and knock-out mouse retinas. J. Neurochem. 106, 2224-2235.
13. Chen T. T., Luque A., Lee S., Anderson S. M., Segura T., and, Iruela-Arispe M. L., (2010) Anchorage of VEGF to the extracellular matrix conveys differential signaling responses to endothelial cells. J. Cell Biol. 188, 595-609.
14. Chiang A., and, Regillo C. D., (2011) Preferred therapies for neovascular age-related macular degeneration. Curr. Opin. Ophthalmol. 22, 199-204.
15. Dal Monte M., Petrucci C., Vasilaki A., Cervia D., Grouselle D., Epelbaum J., Kreienkamp H. J., Richter D., Hoyer D., and, Bagnoli P., (2003) Genetic deletion of somatostatin receptor 1 alters somatostatinergic transmission in the mouse retina. Neuropharmacology 45, 1080-1092.
16. Dal Monte M., Cammalleri M., Martini D., Casini G., and, Bagnoli P., (2007) Antiangiogenic role of somatostatin receptor 2 in a model of hypoxia-induced neovascularization in the retina: results from transgenic mice. Invest. Ophthalmol. Vis. Sci. 48, 3480-3489.
17. Dal Monte M., Ristori C., Cammalleri M., and, Bagnoli P., (2009) Effects of somatostatin analogues on retinal angiogenesis in a mouse model of oxygen-induced retinopathy: involvement of the somatostatin receptor subtype 2. Invest. Ophthalmol. Vis. Sci. 50, 3596-3606.
18. Dal Monte M., Ristori C., Videau C., Loudes C., Martini D., Casini G., Epelbaum J., and, Bagnoli P., (2010) Expression, localization, and functional coupling of the somatostatin receptor subtype 2 in a mouse model of oxygen-induced retinopathy. Invest. Ophthalmol. Vis. Sci. 51, 1848-1856.
19. Dorey C. K., Aouididi S., Reynaud X., Dvorak H. F., and, Brown L. F., (1996) Correlation of vascular permeability factor/vascular endothelial growth factor with extraretinal neovascularization in the rat. Arch. Ophthalmol. 114, 1210-1217.
20. Drager U. C., Edwards D. L., and, Barnstable C. J., (1984) Antibodies against filamentous components in discrete cell types of the mouse retina. J. Neurosci. 4, 2025-2042.
21. Ellis E. A., Guberski D. L., Somogyi-Mann M., and, Grant M. B., (2000) Increased H2O2, vascular endothelial growth factor and receptors in the retina of the BBZ/Wor diabetic rat. Free Radic. Biol. Med. 28, 91-101.
22. Falcon B. L., Barr S., Gokhale P. C., Chou J., Fogarty J., Depeille P., Miglarese M., Epstein D. M., and, McDonald D. M., (2011) Reduced VEGF production, angiogenesis, and vascular regrowth contribute to the antitumor properties of dual mTORC1/mTORC2 inhibitors. Cancer Res. 71, 1573-1583.
23. Favaloro E. J., Moraitis N., Koutts J., Exner T., and, Bradstock K. F., (1989) Endothelial cells and normal circulating haemopoietic cells share a number of surface antigens. Thromb. Haemost. 61, 217-224.
24. Gariano R. F., Hu D., and, Helms J., (2006) Expression of angiogenesis-related genes during retinal development. Gene Expr. Patterns 6, 187-192.
25. Goyal S., Lavalley M., and, Subramanian M. L., (2011) Meta-analysis and review on the effect of bevacizumab in diabetic macular edema. Graefes Arch. Clin. Exp. Ophthalmol. 249, 15-27.
26. Greferath U., Grunert U., and, Wassle H., (1990) Rod bipolar cells in the mammalian retina show protein kinase C-like immunoreactivity. J. Comp. Neurol. 301, 433-442.
27. Haverkamp S., Ghosh K. K., Hirano A. A., and, Wassle H., (2003) Immunocytochemical description of five bipolar cell types of the mouse retina. J. Comp. Neurol. 455, 463-476.
28. Kilic U., Kilic E., Jarve A., Guo Z., Spudich A., Bieber K., Barzena U., Bassetti C. L., Marti H. H., and, Hermann D. M., (2006) Human vascular endothelial growth factor protects axotomized retinal ganglion cells in vivo by activating ERK-1/2 and Akt pathways. J. Neurosci. 26, 12439-12446.
29. Kim S. Y., Mocanu C., McLeod D. S., Bhutto I. A., Merges C., Eid M., Tong P., and, Lutty G. A., (2003) Expression of pigment epithelium-derived factor (PEDF) and vascular endothelial growth factor (VEGF) in sickle cell retina and choroid. Exp. Eye Res. 77, 433-445.
30. Kociok N., Krohne T. U., Poulaki V., and, Joussen A. M., (2007) Geldanamycin treatment reduces neovascularization in a mouse model of retinopathy of prematurity. Graefes Arch. Clin. Exp. Ophthalmol. 245, 258-266.
31. Kreienkamp H. J., Akgun E., Baumeister H., Meyerhof W., and, Richter D., (1999) Somatostatin receptor subtype 1 modulates basal inhibition of growth hormone release in somatotrophs. FEBS Lett. 462, 464-466.
32. Lampugnani M. G., Orsenigo F., Gagliani M. C., Tacchetti C., and, Dejana E., (2006) Vascular endothelial cadherin controls VEGFR-2 internalization and signaling from intracellular compartments. J. Cell Biol. 174, 593-604.
33. Lee I., Lee H., Kim J. M., Chae E. H., Kim S. J., and, Chang N., (2007) Short-term hyperhomocysteinemia-induced oxidative stress activates retinal glial cells and increases vascular endothelial growth factor expression in rat retina. Biosci. Biotechnol. Biochem. 71, 1203-1210.
34. Lutty G. A., McLeod D. S., Merges C., Diggs A., and, Plouet J., (1996) Localization of vascular endothelial growth factor in human retina and choroid. Arch. Ophthalmol. 114, 971-977.
35. Massote P. D., Pinheiro A. C., Fonseca C. G., Prado M. A., Guimaraes A. L., Massensini A. R., and, Gomez M. V., (2008) Protective effect of retinal ischemia by blockers of voltage-dependent calcium channels and intracellular calcium stores. Cell. Mol. Neurobiol. 28, 847-856.
36. Mastrodimou N., Lambrou G. N., and, Thermos K., (2005) Effect of somatostatin analogues on chemically induced ischaemia in the rat retina. Naunyn Schmiedebergs Arch. Pharmacol. 371, 44-53.
37. Mastrodimou N., Kiagiadaki F., Hodjarova M., Karagianni E., and, Thermos K., (2006a) Somatostatin receptors (sst2) regulate cGMP production in rat retina. Regul. Pept. 133, 41-46.
38. Mastrodimou N., Vasilaki A., Papadioti A., Low M. J., Hoyer D., and, Thermos K., (2006b) Somatostatin receptors in wildtype and somatostatin deficient mice and their involvement in nitric oxide physiology in the retina. Neuropeptides 40, 365-373.
39. Mastrodimou N., Kiagiadaki F., and, Thermos K., (2008) The role of nitric oxide and cGMP in somatostatin's protection against retinal ischemia. Invest. Ophthalmol. Vis. Sci. 49, 342-349.
40. Mathews M. K., Merges C., McLeod D. S., and, Lutty G. A., (1997) Vascular endothelial growth factor and vascular permeability changes in human diabetic retinopathy. Invest. Ophthalmol. Vis. Sci. 38, 2729-2741.
41. May C. A., Ohlmann A. V., Hammes H., and, Spandau U. H., (2006) Proteins with an endostatin-like domain in a mouse model of oxygen-induced retinopathy. Exp. Eye Res. 82, 341-348.
42. Osborne N. N., Casson R. J., Wood J. P., Chidlow G., Graham M., and, Melena J., (2004) Retinal ischemia: mechanisms of damage and potential therapeutic strategies. Prog. Retin. Eye Res. 23, 91-147.
43. Pavan B., Fiorini S., Dal Monte M., Lunghi L., Biondi C., Bagnoli P., and, Cervia D., (2004) Somatostatin coupling to adenylyl cyclase activity in the mouse retina. Naunyn Schmiedebergs Arch. Pharmacol. 370, 91-98.
44. Pierce E. A., Avery R. L., Foley E. D., Aiello L. P., and, Smith L. E., (1995) Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization. Proc. Natl. Acad. Sci. U S A 92, 905-909.
45. Prokosch V., Fink J., Heiduschka P., Melkonyan H., and, Thanos S., (2011) VEGF, Ang-2 and SRIF associated abnormal postnatal development of the retinal capillary network in the Royal College of Surgeons rat. Exp. Eye Res. 92, 128-137.
46. Rajappa M., Saxena P., and, Kaur J., (2010) Ocular angiogenesis: mechanisms and recent advances in therapy. Adv. Clin. Chem. 50, 103-121.
47. Ray P. S., Estrada-Hernandez T., Sasaki H., Zhu L., and, Maulik N., (2000) Early effects of hypoxia/reoxygenation on VEGF, ang-1, ang-2 and their receptors in the rat myocardium: implications for myocardial angiogenesis. Mol. Cell. Biochem. 213, 145-153.
48. Santos S. C., Miguel C., Domingues I., Calado A., Zhu Z., Wu Y., and, Dias S., (2007) VEGF and VEGFR-2 (KDR) internalization is required for endothelial recovery during wound healing. Exp. Cell Res. 313, 1561-1574.
49. Snow R. L., and, Robson J. A., (1994) Ganglion cell neurogenesis, migration and early differentiation in the chick retina. Neuroscience 58, 399-409.
50. Stitt A. W., O'Neill C. L., O'Doherty M. T., Archer D. B., Gardiner T. A., and, Medina R. J., (2011) Vascular stem cells and ischaemic retinopathies. Prog. Retin. Eye Res. 30, 149-166.
51. Stone J., Itin A., Alon T., Pe'er J., Gnessin H., Chan-Ling T., and, Keshet E., (1995) Development of retinal vasculature is mediated by hypoxia-induced vascular endothelial growth factor (VEGF) expression by neuroglia. J. Neurosci. 15, 4738-4747.
52. Verma A., Biswas J., Radhakrishnan S., and, Narayanasamy A., (2010) Intra-ocular expression of vascular endothelial growth factor (VEGF) and pigment epithelial-derived factor (PEDF) in a case of Eales' disease by immunohistochemical analysis: a case report. Int. Ophthalmol. 30, 429-434.
53. Watanabe M., Rutishauser U., and, Silver J., (1991) Formation of the retinal ganglion cell and optic fiber layers. J. Neurobiol. 22, 85-96.
54. Weckbecker G., Lewis I., Albert R., Schmid H. A., Hoyer D., and, Bruns C., (2003) Opportunities in somatostatin research: biological, chemical and therapeutic aspects. Nat. Rev. Drug Discov. 2, 999-1017.
55. Yamada H., Yamada E., Hackett S. F., Ozaki H., Okamoto N., and, Campochiaro P. A., (1999) Hyperoxia causes decreased expression of vascular endothelial growth factor and endothelial cell apoptosis in adult retina. J. Cell. Physiol. 179, 149-156.
56. Yi X., Mai L. C., Uyama M., and, Yew D. T., (1998) Time-course expression of vascular endothelial growth factor as related to the development of the retinochoroidal vasculature in rats. Exp. Brain Res. 118, 155-160.
57. Yla-Herttuala S., Rissanen T. T., Vajanto I., and, Hartikainen J., (2007) Vascular endothelial growth factors: biology and current status of clinical applications in cardiovascular medicine. J. Am. Coll. Cardiol. 49, 1015-1026.
58. Zhang X., Bao S., Hambly B. D., and, Gillies M. C., (2009) Vascular endothelial growth factor-A: a multifunctional molecular player in diabetic retinopathy. Int. J. Biochem. Cell Biol. 41, 2368-2371.
59. Zhao T. T., Trinh D., Addison C. L., and, Dimitroulakos J., (2010) Lovastatin inhibits VEGFR and AKT activation: synergistic cytotoxicity in combination with VEGFR inhibitors. PLoS ONE 5, e12563.
60. Zhu X., Li A., Brown B., Weiss E. R., Osawa S., and, Craft C. M., (2002) Mouse cone arrestin expression pattern: light induced translocation in cone photoreceptors. Mol. Vis. 8, 462-471.